The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures. Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project … We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission. Surveillance Population frequency of gene variants predisposing to specific diseases Population frequency of morbidity and mortality from such diseases Population frequency and effects of environmental factors known to interact with gene variants Economic costs of genetic components of diseases Coverage, access, and uptake of genetic tests and services Aetiology Magnitude of disease risk associated with gene variants in different populations Contribution of gene variants to the overall level of disease in different populations Magnitude of disease risk associated with gene–gene and gene–environment interactions in different populations Heal
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The essence of an MR design is that the association between a genetic variant (G) and an outcome (Y) can be used to test whether and by how much the exposure of interest (X) influences the outcome, provided that the genetic variant is associated with the exposure of interest and has no other source of association with the outcome.1,9”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“When initially presented, it was concluded that “[MR] offers a more robust approach to understanding the effect of some modifiable exposures on health outcomes than does much conventional observational epidemiology”1 and that where possible, RCTs should follow to establish the effects of interventions. This conclusion remains unchanged, although moving towards formal triangulation of all pertinent”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Canalization can occur when polymorphic phenotypes expressed during fetal development lead to the development of compensating pathways to mitigate the effects of that expression. 1,178,179”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Estimating effect sizes through the instrumental variable approach imposes a fourth assumption, usually homogeneity of effects of the exposure on the outcome.16 58 59 60”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Most MR studies rely on three core IV assumptions (relevance, independence, and exclusion restriction; fig 1, box 3) to carry out testing for causal effects of the exposure on the outcome.16”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Similarly, violation of the ‘exclusion restriction criteria’33–37 could bias causal estimates in IV analyses when used to test effects of intermediates in RCTs or when used in observational data (including MR)”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“but may be confounded by population stratification.33,34”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“Human genetics can provide compelling evidence of causation through approaches such as Mendelian randomization (MR).”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Performed well, such studies called Mendelian randomization (MR) analyses, can provide rigorous evidence of causation 9,10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“We can exploit the properties of the human genome (specifically, the random segregation of alleles and their non-modifiable nature) to make causal inferences about the relationships between risk factors and disease 10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Mendelian randomization uses genetic variants, assumed to be instrumental variables for a particular exposure, to estimate the causal effect of that exposure on an outcome.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
In the citing paper
“If the instrumental variable criteria are satisfied, the resulting estimator is consistent even in the presence of unmeasured confounding and reverse causation.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,679
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255
Flagged first, then by citations
Research works printed but not linked: 3
- Skrabanek P. False Premises, False Promises. Whithorn: Tarragon Press, 2000.
- http://www.ncbi.nlm.nih.gov/Omim (accessed 12 Dec 2002).
- Heart Protection Study Collaborative Group. MRC/BHF heart protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. Lancet2002;360:7–22. · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 1,037
Education and myopia: assessing the direction of causality by mendelian randomisation
Mountjoy, E., Davies, N. M., Plotnikov, D., Smith, G. D., Rodriguez, S., Williams, C. E., Guggenheim, J. A., & Atan, D. (2018) · BMJ · doi:10.1136/bmj.k2022 · Cited by 299
Burgess, S., Foley, C. N., & Zuber, V. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021731 · Cited by 291
Glymour, M. M., Tchetgen Tchetgen, E. J., & Robins, J. M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr323 · Cited by 292
Use of Mendelian randomisation to assess potential benefit of clinical intervention.
Burgess, S., Butterworth, A., Malarstig, A., & Thompson, S. G. (2012) · BMJ · doi:10.1136/bmj.e7325 · Cited by 292
Heikkilä, K., Harris, R., Lowe, G. D. O., Rumley, A., Yarnell, J., Gallacher, J., Ben‐Shlomo, Y., Ebrahim, S. B. J., & Lawlor, D. A. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 293
Self-citationComparing Within- and Between-Family Polygenic Score Prediction
Selzam, S., Ritchie, S. J., Pingault, J.-B., Reynolds, C. A., O’Reilly, P. F., & Plomin, R. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.06.006 · Cited by 289
Davey Smith, G., Holmes, M. V., Davies, N. M., & Ebrahim, S. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00622-7 · Cited by 287
Self-citationKey concepts in genetic epidemiology
Burton, P. R., Tobin, M. D., & Hopper, J. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67322-9 · Cited by 294
Data Resource Profile: Accessible Resource for Integrated Epigenomic Studies (ARIES)
Relton, C. L., Gaunt, T. R., McArdle, W. L., Ho, K. M., Duggirala, A., Shihab, H. A., Woodward, G., Lyttleton, O., Evans, D. M., Reik, W., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv072 · Cited by 287
Genetic evidence for causal relationships between maternal obesity-related traits and birth weight
Tyrrell, J., Richmond, R. C., Palmer, T. M., Feenstra, B., Rangarajan, J., Metrustry, S., Cavadino, A., Paternoster, L., Armstrong, L. L., De Silva, N. M. G., et al. (2016) · JAMA · doi:10.1001/jama.2016.1975 · Cited by 284
Khandaker, G. M., Zuber, V., Rees, J. M. B., Carvalho, L. A., Mason, A. M., Foley, C. N., Gkatzionis, A., Jones, P. B., & Burgess, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0395-3 · Cited by 287
Palmer, T. M., Nordestgaard, B. G., Benn, M., Tybjaerg-Hansen, A., Davey Smith, G., Lawlor, D. A., & Timpson, N. J. (2013) · BMJ · doi:10.1136/bmj.f4262 · Cited by 282
Haase, C. L., Tybjærg-Hansen, A., Ali Qayyum, A., Schou, J., Nordestgaard, B. G., & Frikke-Schmidt, R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1846 · Cited by 282
Sleep Duration and Myocardial Infarction
Daghlas, I., Dashti, H. S., Lane, J. M., Aragam, K. G., Rutter, M. K., Saxena, R., & Vetter, C. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.022 · Cited by 289
The genetic architecture of economic and political preferences
Benjamin, D. J., Cesarini, D. A., van der Loos, M., Dawes, C. T., Koellinger, P., Magnusson, P. K. E., Chabris, C. F., Conley, D., Laibson, D., Johannesson, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120666109 · Cited by 283
Würtz, P., Wang, Q., Kangas, A. J., Richmond, R. C., Skarp, J., Tiainen, M., Tynkkynen, T., Soininen, P., Havulinna, A. S., Kaakinen, M., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001765 · Cited by 280
Nordestgaard, B. G., Palmer, T., Benn, M., Zacho, J., Tybjærg‐Hansen, A., Smith, G. D., & Timpson, N. J. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001212 · Cited by 284
"Bodies Count," and Body Counts: Social Epidemiology and Embodying Inequality
Krieger, N. (2004) · Epidemiologic Reviews · doi:10.1093/epirev/mxh009 · Cited by 287
Lawlor, D., Smith, G., O'callaghan, M., Alati, R., Mamun, A. A., Williams, G., & Najman, J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwk030 · Cited by 280
Hingorani, A. D., & Humphries, S. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67767-7 · Cited by 277
Fraser, A., Harris, R., Sattar, N. A., Ebrahim, S. B. J., Smith, G. D., & Lawlor, D. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.152298 · Cited by 276
Self-citationThe fat mass–and obesity-associated locus and dietary intake in children
Timpson, N. J., Emmett, P. M., Frayling, T. M., Rogers, I., Hattersley, A. T., McCarthy, M. I., & Smith, G. D. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.4.971 · Cited by 275
Mancuso, N., Shi, H., Goddard, P. C., Kichaev, G., Gusev, A., & Paşaniuc, B. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.031 · Cited by 266
Zhao, W., Rasheed, A., Tikkanen, E., Lee, J., Butterworth, A. S., Howson, J. M. M., Assimes, T. L., Chowdhury, R., Orho‐Melander, M., Damrauer, S. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3943 · Cited by 263
Zhou, S., Butler‐Laporte, G., Nakanishi, T., Morrison, D., Afilalo, J., Afilalo, M., Laurent, L., Pietzner, M., Kerrison, N. D., Zhao, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01281-1 · Cited by 268
Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies
Pearson‐Stuttard, J., Papadimitriou, N., Markozannes, G., Cividini, S., Κακούρου, Α., Gill, D., Rizos, E. C., Monori, G., Ward, H. A., Kyrgiou, M., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1245 · Cited by 281
Kunutsor, S. K., Apekey, T. A., & Khan, H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.006 · Cited by 270
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liverPreprint
Yang, X., Zhang, B., Molony, C. M., Chudin, E., Hao, K., Zhu, J., Gaedigk, A., Suver, C., Zhong, H., Leeder, J. S., et al. (2010) · Genome Research · doi:10.1101/gr.103341.109 · Cited by 279
Kröger, J., Zietemann, V., Enzenbach, C., Weikert, C., Jansen, E. H., Döring, F., Joost, H.-G., Boeing, H., & Schulze, M. B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005447 · Cited by 270
Paternoster, L., Tilling, K., & Davey Smith, G. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006944 · Cited by 271
Larsson, S. C., & Burgess, S. (2021) · BMC Medicine · doi:10.1186/s12916-021-02188-x · Cited by 292
Rao, S., Lau, A., & So, H. (2020) · Diabetes Care · doi:10.2337/dc20-0643 · Cited by 277
The last two decades of life course epidemiology, and its relevance for research on ageing
Ben‐Shlomo, Y., Cooper, R., & Kuh, D. J. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw096 · Cited by 288
Kappelmann, N., Arloth, J., Georgakis, M. K., Czamara, D., Rost, N., Ligthart, S., Khandaker, G. M., & Binder, E. B. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3436 · Cited by 270
Kang, H., Zhang, A., Cai, T. T., & Small, D. S. (2016) · Journal of the American Statistical Association · doi:10.1080/01621459.2014.994705 · Cited by 265
Carreras‐Torres, R., Johansson, M., Gaborieau, V., Haycock, P., Wade, K. H., Relton, C. L., Martin, R. M., Smith, G. D., & Brennan, P. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx012 · Cited by 273
Trajanoska, K., Morris, J. A., Oei, L., Zheng, H.-F., Evans, D. M., Kiel, D. P., Ohlsson, C., Richards, J. B., & Rivadeneira, F. (2018) · BMJ · doi:10.1136/bmj.k3225 · Cited by 270
Obesity and Multiple Sclerosis: A Mendelian Randomization Study
Mokry, L. E., Ross, S., Timpson, N. J., Sawcer, S. J., Smith, G. D., & Richards, J. B. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002053 · Cited by 277
Causal inference with observational data: the need for triangulation of evidence
Hammerton, G., & Munafò, M. R. (2021) · Psychological Medicine · doi:10.1017/s0033291720005127 · Cited by 262
“MR is generally implemented through the use of genetic variants as proxies for the exposure of interest (Davey Smith & Ebrahim, 2003; Davies et al., 2018b).”
The variant call format provides efficient and robust storage of GWAS summary statistics
Lyon, M., Andrews, S. J., Elsworth, B., Gaunt, T. R., Hemani, G., & Marcora, E. M. (2021) · Genome biology · doi:10.1186/s13059-020-02248-0 · Cited by 260
Genetic correlates of social stratification in Great Britain
Abdellaoui, A., Hugh-Jones, D., Yengo, L., Kemper, K. E., Nivard, M. G., Veul, L., Holtz, Y., Zietsch, B. P., Frayling, T. M., Wray, N. R., et al. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0757-5 · Cited by 261
Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants
Kunutsor, S. K., Apekey, T. A., & Steur, M. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9790-2 · Cited by 264
Burton, P. R., Hansell, A., Fortier, I., Manolio, T. A., Khoury, M. J., Little, J., & Elliott, P. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn147 · Cited by 266
Smith, G. D. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00191.x · Cited by 257
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity
Gilbody, S. M., Lightfoot, T., & Sheldon, T. (2007) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.050385 · Cited by 251
Relton, C. L., & Davey Smith, G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000356 · Cited by 254
Budu‐Aggrey, A., Brumpton, B. M., Tyrrell, J., Watkins, S., Modalsli, E. H., Celis-Morales, C. A., Ferguson, L. D., Vie, G. Å., Palmer, T., Fritsche, L. G., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002739 · Cited by 268
Discovery of shared genomic loci using the conditional false discovery rate approach
Smeland, O. B., Frei, O., Shadrin, A. A., O’Connell, K. S., Fan, C. C., Bahrami, S., Holland, D., Djurovic, S., Thompson, W. K., Dale, A. M., et al. (2019) · Human Genetics · doi:10.1007/s00439-019-02060-2 · Cited by 261
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke
Georgakis, M. K., Gill, D., Rannikmäe, K., Traylor, M., Anderson, C. D., Lee, J., Kamatani, Y., Hopewell, J. C., Worrall, B. B., Bernhagen, J., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035905 · Cited by 248
Bowden, J., Hemani, G., & Davey Smith, G. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy185 · Cited by 251
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
Simpkin, A. J., Hemani, G., Suderman, M., Gaunt, T. R., Lyttleton, O., Mcardle, W. L., Ring, S. M., Sharp, G. C., Tilling, K., Horvath, S., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv456 · Cited by 246
Depression and prostate cancer risk: A Mendelian randomization study
Chen, X., Kong, J., Diao, X., Cai, J., Zheng, J., Xie, W., Qin, H., Huang, J., & Lin, T. (2020) · Cancer Medicine · doi:10.1002/cam4.3493 · Cited by 248
Prospects for epigenetic epidemiology
Foley, D. L., Craig, J. M., Morley, R., Olsson, C. J., Dwyer, T., Smith, K., & Saffery, R. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn380 · Cited by 244
Vitamin supplements and the risk for congenital anomalies other than neural tube defects
Botto, L. D., Olney, R. S., & Erickson, J. D. (2004) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30004 · Cited by 244
Serum 25‐hydroxyvitamin D and IgE – a significant but nonlinear relationship
Hyppönen, E., Berry, D. J., Wjst, M., & Power, C. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01865.x · Cited by 243
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis
Muntjewerff, J.-W., Kahn, R. S., Blom, H. J., & den Heijer, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001746 · Cited by 241
A Unified Framework for Association Analysis with Multiple Related Phenotypes
Stephens, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065245 · Cited by 240
Genetics of Obesity: What have we Learned?
Choquet, H., & Meyre, D. (2011) · Current Genomics · doi:10.2174/138920211795677895 · Cited by 253
Zuber, V., Colijn, J. M., Klaver, C. C. W., & Burgess, S. (2020) · Nature Communications · doi:10.1038/s41467-019-13870-3 · Cited by 237
Genetics of circadian rhythms and sleep in human health and disease
Lane, J. M., Qian, J., Mignot, E., Redline, S., Scheer, F. A. J. L., & Saxena, R. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00519-z · Cited by 236
Lyall, D. M., Celis-Morales, C., Ward, J., Iliodromiti, S., Anderson, J. J., Gill, J. M. R., Smith, D. J., Ntuk, U. E., Mackay, D. F., Holmes, M. V., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5804 · Cited by 235
Disentangling molecular relationships with a causal inference test
Millstein, J., Zhang, B., Zhu, J. W., & Schadt, E. E. (2009) · BMC Genetics · doi:10.1186/1471-2156-10-23 · Cited by 234
Lewis, S. J., & Smith, G. D. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0196 · Cited by 234
Küpers, L. K., Monnereau, C., Sharp, G. C., Yousefi, P., Salas, L. A., Ghantous, A., Page, C. M., Reese, S. E., Wilcox, A. J., Czamara, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09671-3 · Cited by 230
Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.047 · Cited by 232
Self-citationGenetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption
Cornelis, M. C., El‐Sohemy, A., & Campos, H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.240 · Cited by 231
Genome-wide Association Study for Vitamin D Levels Reveals 69 Independent Loci
Manousaki, D., Mitchell, R. E., Dudding, T., Haworth, S. J., Harroud, A., Forgetta, V., Shah, R. L., Luan, J., Langenberg, C., Timpson, N. J., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.01.017 · Cited by 230
Psychosocial factors and public health: a suitable case for treatment?
Macleod, J., & Smith, G. D. (2003) · Journal of Epidemiology & Community Health · doi:10.1136/jech.57.8.565 · Cited by 234
Nitsch, D., Molokhia, M., Smeeth, L. L., Stavola, B. L. D., Whittaker, J. C., & Leon, D. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj062 · Cited by 228
Software Application Profile: PHESANT: a tool for performing automated phenome scans in UK Biobank
Millard, L. A. C., Davies, N. M., Gaunt, T. R., Smith, G. D., & Tilling, K. M. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx204 · Cited by 212
(2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm191 · Cited by 227
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
Kronenberg, F. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6648-3 · Cited by 233
Education and coronary heart disease: mendelian randomisation study
Tillmann, T., Vaucher, J., Okbay, A., Pikhart, H., Peasey, A., Kubinova, R., Pajak, A., Tamosiunas, A., Malyutina, S., Hartwig, F. P., et al. (2017) · BMJ · doi:10.1136/bmj.j3542 · Cited by 225
Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia
Upthegrove, R., & Khandaker, G. M. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_88 · Cited by 230
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
Vergeer, M., Holleboom, A. G., Kastelein, J. J. P., & Kuivenhoven, J. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001610 · Cited by 222
Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits
Vogelezang, S., Bradfield, J. P., Ahluwalia, T. S., Curtin, J. A., Lakka, T. A., Grarup, N., Scholz, M. R., van der Most, P. J., Monnereau, C., Stergiakouli, E., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008718 · Cited by 226
Walker, V. M., Smith, G. D., Davies, N. M., & Martin, R. M. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx207 · Cited by 216
The Promises and Pitfalls of Genoeconomics
Benjamin, D. J., Cesarini, D. A., Chabris, C. F., Glaeser, E. L., Laibson, D., Age, G. S.-R. S., Gudnason, V. G., Harris, T. B., Launer, L. J., Purcell, S., et al. (2012) · Annual Review of Economics · doi:10.1146/annurev-economics-080511-110939 · Cited by 217
Perry, J. R. B., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., Thorleifsson, G., Grallert, H., Ferrucci, L., Maggio, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp522 · Cited by 217
Commentary: The concept of 'Mendelian Randomization'
Thomas, D. C. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh048 · Cited by 217
The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?
Smith, A. D. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s119 · Cited by 221
Assumptions of IV Methods for Observational Epidemiology.
Didelez, V., Meng, S., & Sheehan, N. A. (2010) · Statistical Science · doi:10.1214/09-sts316 · Cited by 214
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk
Rhead, B., Bäärnhielm, M., Gianfrancesco, M. A., Mok, A., Shao, X., Quach, H., Shen, L., Schaefer, C. A., Link, J., Gyllenberg, A., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000097 · Cited by 225
The genetic basis of major depression
Kendall, K. M., Van Assche, E., Andlauer, T. F. M., Choi, K. W., Luykx, J. J., Schulte, E. C., & Lu, Y. (2021) · Psychological Medicine · doi:10.1017/s0033291721000441 · Cited by 213
Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
Walker, K. A., Chen, J., Zhang, J., Fornage, M., Yang, Y., Zhou, L., Grams, M. E., Tin, A., Daya, N., Hoogeveen, R. C., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00064-0 · Cited by 212
Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls
Kavvoura, F. K., & Ioannidis, J. P. A. (2007) · Human Genetics · doi:10.1007/s00439-007-0445-9 · Cited by 209
Munafo, M. R., Timofeeva, M. N., Morris, R. W., Prieto‐Merino, D., Sattar, N. A., Brennan, P., Johnstone, E. C., Relton, C. L., Johnson, P., Walther, D. M., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs191 · Cited by 215
Self-citation‘Mendelian randomization’: an approach for exploring causal relations in epidemiology
Gupta, V., Walia, G. K., & SACHDEVA, M. P. (2017) · Public Health · doi:10.1016/j.puhe.2016.12.033 · Cited by 216
Storm, C. S., Kia, D. A., Almramhi, M. M., Bandrés‐Ciga, S., Finan, C., Noyce, A. J., Kaiyrzhanov, R. B., Middlehurst, B., Tan, M. M. X., Houlden, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26280-1 · Cited by 213
Association of C-Reactive Protein With Blood Pressure and Hypertension
Smith, G. D., Lawlor, D. A., Harbord, R. M., Timpson, N. J., Rumley, A., Lowe, G. D. O., Day, I. N. M., & Ebrahim, S. B. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160351.95181.d0 · Cited by 212
Self-citationLagnado, D. A., Waldmann, M. R., Hagmaye, Y., & Sloman, S. A. (2007) · doi:10.1093/acprof:oso/9780195176803.003.0011 · Cited by 209
Essential Epidemiology: An Introduction for Students and Health Professionals
Webb, P. M., & Bain, C. (2012) · Cited by 209
Instrumental Variable Analysis with a Nonlinear Exposure–Outcome Relationship
Burgess, S., Davies, N. M., & Thompson, S. G. (2014) · Epidemiology · doi:10.1097/ede.0000000000000161 · Cited by 210
Qi, G., & Chatterjee, N. (2019) · Nature Communications · doi:10.1038/s41467-019-09432-2 · Cited by 207
Clarke, R., Bennett, D., Parish, S., Verhoef, P., Dötsch‐Klerk, M., Lathrop, M. G., Xu, P., Nordestgaard, B. G., Hólm, H., Hopewell, J. C., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001177 · Cited by 207
Field Experiments and the Study of Voter Turnout
GREEN, D. P., McGrath, M. C., & Aronow, P. M. (2012) · Journal of Elections Public Opinion and Parties · doi:10.1080/17457289.2012.728223 · Cited by 207
Kamstrup, P. R., & Nordestgaard, B. G. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.08.006 · Cited by 206
C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies
Tsilidis, K. K., Branchini, C., Güallar, E., Helzlsouer, K. J., Erlinger, T. P., & Platz, E. A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23606 · Cited by 203
Plasma Albumin and Incident Cardiovascular Disease
Ronit, A., Kirkegaard-Klitbo, D. M., Dohlmann, T. L., Lundgren, J. D., Sabin, C. A., Phillips, A. N., Nordestgaard, B. G., & Afzal, S. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313681 · Cited by 205
Metadata
- Authors
- Davey Smith, G., & Ebrahim, S.
- ORCID
- Ebrahim, Shah
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02
- Volume
- 32
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2106036991
- Cited by
- 5,882
- References
- 179
- Citations by year
- 2026: 333 · 2025: 673 · 2024: 1162 · 2023: 681 · 2022: 453 · 2021: 442 · 2020: 353 · 2019: 235 · 2018: 201 · 2017: 157 · 2016: 163 · 2015: 118 · 2014: 115 · 2013: 94 · 2012: 101
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- Mendelian randomization, genetic epidemiology, environmental factors in disease, causal inference, confounding, reverse causality, linkage disequilibrium, canalization, genetic polymorphism, genetic testing, public health genetics, disease prevention, Human Genome Project, pathogenesis, cancer genetics
- MeSH terms
- Animals, Disease, Environmental Exposure, Genotype, Humans, Polymorphism, Genetic, Molecular Epidemiology, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
